Corvus Pharmaceuticals
CRVS • NASDAQ • Stock Fundamentals
Corvus Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard A. Miller, with a market cap of $975.4M.
Market Cap$975.4M
Employees28.0
CEORichard A. Miller
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Corvus Pharmaceuticals FAQ
Common questions about Corvus Pharmaceuticals
Corvus Pharmaceuticals (CRVS) has a market capitalization of $975.4M and trades on NASDAQ.
Corvus Pharmaceuticals has approximately 28 employees.